Recent progress in the development of new antimalarial drugs with novel targets

TM Belete - Drug design, development and therapy, 2020 - Taylor & Francis
Malaria is a major global health problem that causes significant mortality and morbidity
annually. The therapeutic options are scarce and massively challenged by the emergence of …

[HTML][HTML] Artemisinin and multidrug-resistant Plasmodium falciparum–a threat for malaria control and elimination

M Dhorda, C Amaratunga… - Current opinion in …, 2021 - journals.lww.com
Enhancing the geographic coverage of surveillance for resistance will be key to ensure
prompt detection of emerging resistance in order to implement effective countermeasures …

Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors

AJ Owoloye, FC Ligali, OA Enejoh, AZ Musa, O Aina… - PloS one, 2022 - journals.plos.org
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New
drugs are required for ancillary support of existing malaria control efforts. Plasmodium …

Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay

JM Dziekan, H Yu, D Chen, L Dai, G Wirjanata… - Science translational …, 2019 - science.org
Mechanisms of action (MoAs) have been elusive for most antimalarial drugs in clinical use.
Decreasing responsiveness to antimalarial treatments stresses the need for a better …

[HTML][HTML] Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination

M Ouji, JM Augereau, L Paloque, F Benoit-Vical - Parasite, 2018 - ncbi.nlm.nih.gov
The use of artemisinin-based combination therapies (ACTs), which combine an artemisinin
derivative with a partner drug, in the treatment of uncomplicated malaria has largely been …

Hijacking factor H for complement immune evasion

SR Moore, SS Menon, C Cortes… - Frontiers in …, 2021 - frontiersin.org
The complement system is an essential player in innate and adaptive immunity. It consists of
three pathways (alternative, classical, and lectin) that initiate either spontaneously …

Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an …

J Landier, DM Parker, AM Thu, KM Lwin, G Delmas… - The Lancet, 2018 - thelancet.com
Summary Background Potentially untreatable Plasmodium falciparum malaria threatens the
Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia …

Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants

SR Bonam, L Rénia, G Tadepalli, J Bayry, HMS Kumar - Vaccines, 2021 - mdpi.com
Malaria—a parasite vector-borne disease—is a global health problem, and Plasmodium
falciparum has proven to be the deadliest among Plasmodium spp., which causes malaria in …

Enhancing the antimalarial activity of artesunate

JO Adebayo, H Tijjani, AP Adegunloye, AA Ishola… - Parasitology …, 2020 - Springer
The global challenge to the treatment of malaria is mainly the occurrence of resistance of
malaria parasites to conventionally used antimalarials. Artesunate, a semisynthetic …

Chloroquine and sulfadoxine–pyrimethamine resistance in Sub-Saharan Africa—A review

AT Roux, L Maharaj, O Oyegoke, OP Akoniyon… - Frontiers in …, 2021 - frontiersin.org
Malaria is a great concern for global health and accounts for a large amount of morbidity and
mortality, particularly in Africa, with sub-Saharan Africa carrying the greatest burden of the …